Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-23 12:14 pm Purchase |
2023-01-10 | 13G | Revolution Medicines, Inc. RVMD |
EcoR1 Capital LLC | 4,478,050 5.000% |
199,981 (+4.67%) |
Filing History |
| 2022-12-09 1:50 pm Purchase |
2022-11-30 | 13G | Revolution Medicines, Inc. RVMD |
Wellington Management Group LLP | 8,936,469 10.060% |
4,425,574 (+98.11%) |
Filing History |
| 2022-09-29 7:49 pm Purchase |
2022-09-22 | 13G | Revolution Medicines, Inc. RVMD |
BB Biotech AG | 4,602,562 5.200% |
4,602,562 (New Position) |
Filing History |
| 2022-06-27 4:33 pm Purchase |
2022-06-16 | 13G | Revolution Medicines, Inc. RVMD |
EcoR1 Capital LLC | 4,278,069 5.800% |
4,278,069 (New Position) |
Filing History |
| 2022-05-10 10:13 am Sale |
2022-05-09 | 13G | Revolution Medicines, Inc. RVMD |
FMR LLC | 186,261 0.250% |
-5,915,463 (-96.95%) |
Filing History |
| 2022-02-14 5:02 pm Sale |
2021-12-31 | 13G | Revolution Medicines, Inc. RVMD |
Third Rock Ventures III L.P. | 5,653,290 7.700% |
-3,295,779 (-36.83%) |
Filing History |
| 2022-02-14 3:10 pm Sale |
2021-12-31 | 13G | Revolution Medicines, Inc. RVMD |
Cormorant Asset Management LP | 2,431,852 3.300% |
-1,243,148 (-33.83%) |
Filing History |
| 2022-02-11 8:57 pm Sale |
2021-12-31 | 13G | Revolution Medicines, Inc. RVMD |
BIOTECHNOLOGY VALUE FUND L P | 1,810,549 2.500% |
-1,946,500 (-51.81%) |
Filing History |
| 2022-02-11 4:23 pm Sale |
2021-12-31 | 13G | Revolution Medicines, Inc. RVMD |
COLUMN GROUP III LP | 3,347,199 4.500% |
-233,007 (-6.51%) |
Filing History |
| 2022-02-10 08:32 am Purchase |
2021-12-31 | 13G | Revolution Medicines, Inc. RVMD |
The Vanguard Group | 6,299,609 8.550% |
2,261,789 (+56.02%) |
Filing History |
| 2022-02-04 09:22 am Purchase |
2021-12-31 | 13G | Revolution Medicines, Inc. RVMD |
Wellington Management Group LLP | 4,510,895 6.120% |
4,510,895 (New Position) |
Filing History |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Revolution Medicines, Inc. RVMD |
BlackRock Inc. BLK |
5,475,219 7.400% |
1,963,132 (+55.90%) |
Filing History |
| 2022-01-10 1:26 pm Sale |
2022-01-07 | 13G | Revolution Medicines, Inc. RVMD |
FMR LLC | 6,101,724 8.280% |
-3,237,761 (-34.67%) |
Filing History |
| 2021-05-19 4:09 pm Purchase |
2021-05-18 | 13G | Revolution Medicines, Inc. RVMD |
Cormorant Asset Management LP | 3,675,000 5.000% |
1,179,934 (+47.29%) |
Filing History |
| 2021-05-17 4:49 pm Purchase |
2021-05-06 | 13G | Revolution Medicines, Inc. RVMD |
BIOTECHNOLOGY VALUE FUND L P | 3,757,049 5.100% |
3,757,049 (New Position) |
Filing History |
| 2021-02-16 4:50 pm Purchase |
2020-12-31 | 13G | Revolution Medicines, Inc. RVMD |
Boxer Capital LLC | 3,309,264 4.600% |
49,500 (+1.52%) |
Filing History |
| 2021-02-16 4:09 pm Purchase |
2020-12-31 | 13G | Revolution Medicines, Inc. RVMD |
Third Rock Ventures III L.P. | 8,949,069 13.500% |
8,949,069 (New Position) |
Filing History |
| 2021-02-16 3:00 pm Sale |
2020-12-31 | 13G | Revolution Medicines, Inc. RVMD |
Cormorant Asset Management LP | 2,495,066 3.800% |
-750,111 (-23.11%) |
Filing History |
| 2021-02-12 6:25 pm Purchase |
2020-12-31 | 13G | Revolution Medicines, Inc. RVMD |
COLUMN GROUP III LP | 3,580,206 4.900% |
3,580,206 (New Position) |
Filing History |
| 2021-02-11 10:46 am Purchase |
2020-02-13 | 13G | Fulcrum Therapeutics, Inc. FULC |
SANOFI | 3,363,050 4.600% |
3,363,050 (New Position) |
Filing History |